BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 17533368)

  • 1. TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways.
    Lehen'kyi V; Flourakis M; Skryma R; Prevarskaya N
    Oncogene; 2007 Nov; 26(52):7380-5. PubMed ID: 17533368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRPV6 potentiates calcium-dependent cell proliferation.
    Schwarz EC; Wissenbach U; Niemeyer BA; Strauss B; Philipp SE; Flockerzi V; Hoth M
    Cell Calcium; 2006 Feb; 39(2):163-73. PubMed ID: 16356545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium store contents control the expression of TRPC1, TRPC3 and TRPV6 proteins in LNCaP prostate cancer cell line.
    Pigozzi D; Ducret T; Tajeddine N; Gala JL; Tombal B; Gailly P
    Cell Calcium; 2006 May; 39(5):401-15. PubMed ID: 16529812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid effects of 17beta-estradiol on epithelial TRPV6 Ca2+ channel in human T84 colonic cells.
    Irnaten M; Blanchard-Gutton N; Harvey BJ
    Cell Calcium; 2008 Nov; 44(5):441-52. PubMed ID: 18395250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression.
    Fixemer T; Wissenbach U; Flockerzi V; Bonkhoff H
    Oncogene; 2003 Oct; 22(49):7858-61. PubMed ID: 14586412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen inhibits TRPV6 activity via estrogen receptor-independent pathways in TRPV6-expressing MCF-7 breast cancer cells.
    Bolanz KA; Kovacs GG; Landowski CP; Hediger MA
    Mol Cancer Res; 2009 Dec; 7(12):2000-10. PubMed ID: 19996302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry.
    Lallet-Daher H; Roudbaraki M; Bavencoffe A; Mariot P; Gackière F; Bidaux G; Urbain R; Gosset P; Delcourt P; Fleurisse L; Slomianny C; Dewailly E; Mauroy B; Bonnal JL; Skryma R; Prevarskaya N
    Oncogene; 2009 Apr; 28(15):1792-806. PubMed ID: 19270724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPV6 and prostate cancer: cancer growth beyond the prostate correlates with increased TRPV6 Ca2+ channel expression.
    Wissenbach U; Niemeyer B; Himmerkus N; Fixemer T; Bonkhoff H; Flockerzi V
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1359-63. PubMed ID: 15336984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CaT1 expression correlates with tumor grade in prostate cancer.
    Peng JB; Zhuang L; Berger UV; Adam RM; Williams BJ; Brown EM; Hediger MA; Freeman MR
    Biochem Biophys Res Commun; 2001 Apr; 282(3):729-34. PubMed ID: 11401523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential role of transient receptor potential channels in Ca2+ entry and proliferation of prostate cancer epithelial cells.
    Thebault S; Flourakis M; Vanoverberghe K; Vandermoere F; Roudbaraki M; Lehen'kyi V; Slomianny C; Beck B; Mariot P; Bonnal JL; Mauroy B; Shuba Y; Capiod T; Skryma R; Prevarskaya N
    Cancer Res; 2006 Feb; 66(4):2038-47. PubMed ID: 16489003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of calcium influx and signaling pathway in cancer cells via TRPV6-Numb1 interaction.
    Kim SY; Yang D; Myeong J; Ha K; Kim SH; Park EJ; Kim IG; Cho NH; Lee KP; Jeon JH; So I
    Cell Calcium; 2013 Feb; 53(2):102-11. PubMed ID: 23140583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory effect of TRPV6 silencing on prostate cancer cell line LNCaP in vitro].
    Zhao XZ; Guo HQ; Liu GX; Ji CW; Zhang SW; Liu TS; Gan WD; Li XG
    Zhonghua Nan Ke Xue; 2010 May; 16(5):423-7. PubMed ID: 20684323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPV6 modulates proliferation of human pancreatic neuroendocrine BON-1 tumour cells.
    Skrzypski M; Kołodziejski PA; Mergler S; Khajavi N; Nowak KW; Strowski MZ
    Biosci Rep; 2016 Aug; 36(4):. PubMed ID: 27450545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPV6.
    Wissenbach U; Niemeyer BA
    Handb Exp Pharmacol; 2007; (179):221-34. PubMed ID: 17217060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor-induced neuroendocrine differentiation and apoptotic resistance of androgen-independent human prostate cancer cells.
    Humez S; Monet M; Legrand G; Lepage G; Delcourt P; Prevarskaya N
    Endocr Relat Cancer; 2006 Mar; 13(1):181-95. PubMed ID: 16601287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular zinc and zinc-citrate, acting through a putative zinc-sensing receptor, regulate growth and survival of prostate cancer cells.
    Dubi N; Gheber L; Fishman D; Sekler I; Hershfinkel M
    Carcinogenesis; 2008 Sep; 29(9):1692-700. PubMed ID: 18310092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts.
    Masuyama R; Vriens J; Voets T; Karashima Y; Owsianik G; Vennekens R; Lieben L; Torrekens S; Moermans K; Vanden Bosch A; Bouillon R; Nilius B; Carmeliet G
    Cell Metab; 2008 Sep; 8(3):257-65. PubMed ID: 18762026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q; Titus MA; Fung KM; Lin HK
    J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRPV6 calcium channel translocates to the plasma membrane via Orai1-mediated mechanism and controls cancer cell survival.
    Raphaël M; Lehen'kyi V; Vandenberghe M; Beck B; Khalimonchyk S; Vanden Abeele F; Farsetti L; Germain E; Bokhobza A; Mihalache A; Gosset P; Romanin C; Clézardin P; Skryma R; Prevarskaya N
    Proc Natl Acad Sci U S A; 2014 Sep; 111(37):E3870-9. PubMed ID: 25172921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer.
    Yeh AH; Jeffery PL; Duncan RP; Herington AC; Chopin LK
    Clin Cancer Res; 2005 Dec; 11(23):8295-303. PubMed ID: 16322288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.